Treatment of Hyperpigmentation

Seminars in Cutaneous Medicine and Surgery

Volumn 30, Issue 3, 2011, Pages 171-175

  Woolery Lloyd, Heather ^a,b   Kammer, Jenna N ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Dyschromia; Hydroquinone; Hyperpigmentation; Melasma; Ochronosis

Indexed keywords

ACNE; CONTACT DERMATITIS; ECZEMA; HYPERPIGMENTATION; HYPOPIGMENTATION; INFLAMMATION; REVIEW; SKIN INJURY; SKIN IRRITATION;

ANIMALS; DERMATOLOGIC AGENTS; HUMANS; HYDROQUINONES; HYPERPIGMENTATION; OCHRONOSIS; PHYTOTHERAPY; PLANT PREPARATIONS; SKIN PIGMENTATION;

EID: 80053043555     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.1016/j.sder.2011.06.004     Document Type: Review

References (38)

1. Palumbo A., d'Ischia M., Misuraca G., et al. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta 1991, 1073:85-90.
2. Jimbow K., Obata H., Pathak M.A., et al. Mechanism of depigmentation by hydroquinone. J Invest Dermatol 1974, 62:436-449.
3. Halder R.M., Richards G.M. Topical agents used in the management of hyperpigmentation. Skin Ther Lett 2004, 9:1-3.
4. Huang P.Y., Chu C.Y. Allergic contact dermatitis due to sodium metabisulfite in a bleaching cream. Contact Dermatitis 2007, 56:123-124.
5. Lawrence N., Bligard C.A., Reed R., et al. Exogenous ochronosis in the United States. J Am Acad Dermatol 1988, 18:1207-1211.
6. Akiu S., Suzuki Y., Asahara T., et al. Inhibitory effect of arbutin on melanogenesis-biochemical study using cultured B16 melanoma cella. J Dermatol 1991, 101:609-613.
7. Kahn V. Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine, and dopamine by mushroom tyrosinase. Pigment Cell Res 1995, 8:234-240.
8. Shigeta Y., Imanaka H., Ando H., et al. Skin Whitening Effect of linoleic acid Is Enhanced by liposomal Formulations. Biol Pharm Bull 2004, 27:591-594.
9. Ando H., Ryu A., Hashimoto A., et al. Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin. Arch Dermatol Res 1998, 290:375-381.
10. Ertam I., Mutlu B., Unal I., et al. Efficiency of ellagic acid and arbutin in melasma: A randomized, prospective, open-label study. J Dermatol 2008, 35:570-574.
11. Hanamura T. Skin lightening effect of polyphenol extract of Acerola fruit on UVB induced pigmentation. Biosci Biotechnol Biochem 2008, 72:3211-3218.
12. Kasraee B., Handjani F., Parhizgar A., et al. Topical methimazole as a new treatment for postinflammatory hyperpigmentation: Report of the first case. Dermatology 2005, 211:360-362.
13. Kasraee B. Depigmentation of brown Guinea pig skin by topical application of methimazole. J Invest Dermatol 2002, 118:205-207.
14. Tirado-Sánchez A., Santamaría-Román A., Ponce-Olivera R.M. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma. Int J Dermatol 2009, 48:893-895.
15. Babiarz-Magee L., Chen N., Seiberg M., et al. The expression and activation of protease-activated receptor-2 correlate with skin color. Pigment Cell Res 2004, 17:241-251.
16. Paine C., Sharlow E., Liebel F. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. J Invest Dermatol 2001, 116:585-595.
17. Wallo W., Nebus J., Leyden J.J. Efficacy of a soy moisturizer in photoaging: A double-blind, vehicle-controlled, 12-week study. J Drugs Dermatol 2007, 6:917-922.
18. Khemis A., Kaiafa A., Queille-Roussel C., et al. Evaluation of efficacy and safety of rucinol serum in patients with melasma: A randomized controlled trial. Br J Dermatol 2007, 156:997-1004.
19. Yokota T., Nishio H., Kubota Y., et al. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 1998, 11:355-361.
20. Kolbe L., Immeyer J., Batzer J., et al. Anti-inflammatory efficacy of licochalcone A: Correlation of clinical potency and in vitro effects. Arch Dermatol Res 2006, 298:23-30.
21. Amer M., Metwalli M. Topical liquiritin improves melasma. Int J Dermatol 2000, 39:299-301.
22. Catani M.V., Rossi A., Costanzo A., et al. Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. Biochem J 2001, 15:77-85.
23. Dreher F., Maibach H. Protective effects of topical antioxidants in humans. Curr Probl Dermatol 2001, 29:157-164.
24. Darr D., Combs S., Dunston S., et al. Topical vitamin C protects porcine skin from ultraviolet radiation-induced damage. Br J Dermatol 1992, 127:247-251.
25. Espinal-Perez L.E., Moncada B., Castanedo-Cazares J.P. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol 2004, 43:604-607.
26. Huh C.H., Seo K.I., Park J.Y., et al. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatology 2003, 206:316-320.
27. Bissett D.L., Farmer T., McPhail S., et al. Genomic expression changes induced by topical N-acetyl glucosamine in skin equivalent cultures in vitro. J Cosmet Dermatol 2007, 6:232-238.
28. Hakozaki T., Minwalla L., Zhuang J., et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002, 147:20-31.
29. Bissett D.L., Robinson L.R., Raleigh P.S., et al. Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol 2007, 6:20-26.
30. Hantash B.M., Jimenez F. A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma. J Drugs Dermatol 2009, 8:732-735.
31. McDaniel D.H., Wu J. Efficacy of a natural-based bleaching cream versus hydroquinone 4% bleaching gel in the treatment of hyperpigmentation. Cosmet Dermatol 2008, 21:596-602.
32. Draelos Z.D., Yatskayer M., Bhushan P., et al. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening. Cutis 2010, 86:153-158.
33. Lee W.R., Shen S.C., Kuo-Hsien W., et al. Lasers and microdermabrasion enhance and control topical delivery of vitamin C. J Invest Dermatol 2003, 121:1118-1125.
34. P Rajan, PE Grimes Skin barrier changes induced by aluminum oxide and sodium chloride microdermabrasion. Dermatol Surg 2002, 28:390-393.
35. Ilknur T., Biçak M.U., Demirtaşoǧlu M., et al. Glycolic acid peels versus amino fruit acid peels in the treatment of melasma. Dermatol Surg 2010, 36:490-495.
36. Hurley M.E., Guevara I.L., Gonzales R.M., et al. Efficacy of glycolic acid peels in the treatment of melasma. Arch Dermatol 2002, 138:1578-1582.
37. Kodali S., Guevara I.L., Carrigan C.R., et al. A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women. J Am Acad Dermatol 2010, 63:1030-1035.
38. Sarkar R., Kaur C., Bhalla M., et al. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: A comparative study. Dermatol Surg 2002, 28:828-832. discussion: 832.